Literature DB >> 21391122

Quercetin's effects on intestinal polyp multiplicity and macrophage number in the Apc(Min/+) mouse.

E Angela Murphy1, J Mark Davis, Jamie L McClellan, Martin D Carmichael.   

Abstract

Numerous in vitro studies argue for quercetin's chemopreventive potential in colon cancer; however, experimental studies in rodents are limited. Macrophages play a role in tumorigenesis, but the effects of quercetin on macrophage infiltration in colon cancer is unknown. We examined the effects of quercetin on intestinal polyp multiplicity and macrophage number in Apc(Min/+) mice. Apc(Min/+) mice were assigned to placebo or quercetin (n = 8/group) groups. Mice were given a placebo or quercetin (0.02%) diet from 4-20 wk of age, after which intestines were analyzed for polyp number and size in the small intestine (Sections 1-4) and colon (Section 5) and for macrophage number in the small intestine (Sections 1 and 3). Spleen weight was determined as a marker of systemic inflammation. Quercetin decreased total intestinal polyps by 67% (P < 0.05). Specifically, quercetin reduced intestinal polyps in categories >2 mm (69%) and 1-2 mm (79%; P < 0.05), and in Sections 2 (75%), 3 (80%), and 4 (79%; P < 0.05). Quercetin also decreased macrophage number in Sections 1 (57%) and 3 (81%), and spleen weight (P < 0.05). These data suggest that quercetin can reduce polyp number and size distribution in the Apc(Min/+) mouse and that these effects may be related to a reduction in macrophage infiltration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21391122      PMCID: PMC3377437          DOI: 10.1080/01635581.2011.535954

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  38 in total

1.  Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia.

Authors:  E E Deschner; J Ruperto; G Wong; H L Newmark
Journal:  Carcinogenesis       Date:  1991-07       Impact factor: 4.944

Review 2.  Signal transduction of inflammatory cytokines and tumor development.

Authors:  Akihiko Yoshimura
Journal:  Cancer Sci       Date:  2006-06       Impact factor: 6.716

Review 3.  Naturally occurring NF-kappaB inhibitors.

Authors:  Nguyen-Hai Nam
Journal:  Mini Rev Med Chem       Date:  2006-08       Impact factor: 3.862

4.  Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin).

Authors:  Suresh R Volate; Destiny M Davenport; Stephanie J Muga; Michael J Wargovich
Journal:  Carcinogenesis       Date:  2005-04-14       Impact factor: 4.944

5.  Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2).

Authors:  Ana Belén Granado-Serrano; María Angeles Martín; Laura Bravo; Luis Goya; Sonia Ramos
Journal:  J Nutr       Date:  2006-11       Impact factor: 4.798

6.  The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression.

Authors:  Desiree Camuesco; Monica Comalada; M Elena Rodríguez-Cabezas; Ana Nieto; Maria D Lorente; Angel Concha; Antonio Zarzuelo; Julio Gálvez
Journal:  Br J Pharmacol       Date:  2004-11-08       Impact factor: 8.739

7.  Tissue distribution of quercetin in rats and pigs.

Authors:  Vincent C J de Boer; Ashwin A Dihal; Hester van der Woude; Ilja C W Arts; Siegfried Wolffram; Gerrit M Alink; Ivonne M C M Rietjens; Jaap Keijer; Peter C H Hollman
Journal:  J Nutr       Date:  2005-07       Impact factor: 4.798

Review 8.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

9.  Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma.

Authors:  Daniela De Stefano; Maria Chiara Maiuri; Vittorio Simeon; Gianluca Grassia; Antonio Soscia; Maria Pia Cinelli; Rosa Carnuccio
Journal:  Eur J Pharmacol       Date:  2007-04-06       Impact factor: 4.432

10.  The antimutagenic activity of the major flavonoids of rooibos (Aspalathus linearis): some dose-response effects on mutagen activation-flavonoid interactions.

Authors:  Petra W Snijman; Sonja Swanevelder; Elizabeth Joubert; Ivan R Green; Wentzel C A Gelderblom
Journal:  Mutat Res       Date:  2007-04-21       Impact factor: 2.433

View more
  17 in total

1.  Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice.

Authors:  Kandy T Velázquez; Reilly T Enos; Aditi A Narsale; Melissa J Puppa; J Mark Davis; E Angela Murphy; James A Carson
Journal:  J Nutr       Date:  2014-04-23       Impact factor: 4.798

2.  Association of dietary quercetin with reduced risk of proximal colon cancer.

Authors:  Zora Djuric; Richard K Severson; Ikuko Kato
Journal:  Nutr Cancer       Date:  2012-03-19       Impact factor: 2.900

3.  Optimization of β-cyclodextrin-based flavonol extraction from apple pomace using response surface methodology.

Authors:  Indu Parmar; Sowmya Sharma; H P Vasantha Rupasinghe
Journal:  J Food Sci Technol       Date:  2014-02-15       Impact factor: 2.701

4.  Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.

Authors:  Temesgen Samuel; Khalda Fadlalla; Lachundra Mosley; Venkat Katkoori; Timothy Turner; Upender Manne
Journal:  Anticancer Res       Date:  2012-01       Impact factor: 2.480

5.  Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in ApcMin/+ Mice.

Authors:  Ashish Saxena; Ravinder Tammali; Kota V Ramana; Satish K Srivastava
Journal:  Curr Cancer Drug Targets       Date:  2018       Impact factor: 3.428

6.  Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.

Authors:  Kimbell L Hetzler; Justin P Hardee; Melissa J Puppa; Aditi A Narsale; Shuichi Sato; J Mark Davis; James A Carson
Journal:  Biochim Biophys Acta       Date:  2014-12-30

Review 7.  Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors:  Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

8.  Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer.

Authors:  Jl Steiner; Jm Davis; Jl McClellan; Rt Enos; Ja Carson; R Fayad; M Nagarkatti; Ps Nagarkatti; D Altomare; Ke Creek; Ea Murphy
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

9.  Dietary quercetin reduces chemotherapy-induced fatigue in mice.

Authors:  Sara E Mahoney; J Mark Davis; E Angela Murphy; Jamie L McClellan; Marjory M Pena
Journal:  Integr Cancer Ther       Date:  2014-03-13       Impact factor: 3.279

10.  Microencapsulated Bifidobacterium bifidum and Lactobacillus gasseri in Combination with Quercetin Inhibit Colorectal Cancer Development in ApcMin/+ Mice.

Authors:  Iván Benito; Ignacio J Encío; Fermín I Milagro; María Alfaro; Ana Martínez-Peñuela; Miguel Barajas; Florencio Marzo
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.